Hao Lu

1.2k total citations
40 papers, 881 citations indexed

About

Hao Lu is a scholar working on Infectious Diseases, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Hao Lu has authored 40 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Molecular Biology and 10 papers in Molecular Medicine. Recurrent topics in Hao Lu's work include Antibiotic Resistance in Bacteria (10 papers), Streptococcal Infections and Treatments (7 papers) and Tuberculosis Research and Epidemiology (6 papers). Hao Lu is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Streptococcal Infections and Treatments (7 papers) and Tuberculosis Research and Epidemiology (6 papers). Hao Lu collaborates with scholars based in China, United States and Germany. Hao Lu's co-authors include Peter J. Tonge, Caroline Kisker, Richard A. Slayden, Chen Tan, J. Schiebel, Wenjia Lu, Andrew Chang, Guillermina Font, Mónica Fernández-Franzón and María-José Ruiz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Accounts of Chemical Research.

In The Last Decade

Hao Lu

38 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Lu China 16 410 253 245 175 128 40 881
Sergio Lociuro Switzerland 18 547 1.3× 282 1.1× 225 0.9× 356 2.0× 155 1.2× 37 1.3k
Anatoly Severin United States 16 516 1.3× 208 0.8× 323 1.3× 137 0.8× 112 0.9× 24 981
Tania J. Lupoli United States 19 769 1.9× 181 0.7× 184 0.8× 200 1.1× 68 0.5× 34 1.2k
David J. Haydon United Kingdom 14 805 2.0× 222 0.9× 160 0.7× 252 1.4× 80 0.6× 18 1.5k
Rajmohan Rajamuthiah United States 16 498 1.2× 131 0.5× 235 1.0× 189 1.1× 230 1.8× 24 1.0k
Anjan Debnath United States 24 687 1.7× 225 0.9× 559 2.3× 87 0.5× 75 0.6× 61 1.8k
Namita Surolia India 18 559 1.4× 355 1.4× 154 0.6× 95 0.5× 268 2.1× 31 1.2k
Gianfranco De Pascale Canada 13 483 1.2× 167 0.7× 265 1.1× 509 2.9× 98 0.8× 20 1.1k
Mack Kuo United States 9 434 1.1× 362 1.4× 398 1.6× 106 0.6× 101 0.8× 11 901
Ellen Z. Baum United States 19 501 1.2× 203 0.8× 127 0.5× 153 0.9× 58 0.5× 26 997

Countries citing papers authored by Hao Lu

Since Specialization
Citations

This map shows the geographic impact of Hao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Lu more than expected).

Fields of papers citing papers by Hao Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Lu. The network helps show where Hao Lu may publish in the future.

Co-authorship network of co-authors of Hao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Lu. A scholar is included among the top collaborators of Hao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Lu. Hao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuqing, et al.. (2025). Carmofur Exhibits Antimicrobial Activity Against Streptococcus pneumoniae. Antibiotics. 14(3). 231–231.
2.
Lü, Yuan, et al.. (2024). Identification of potential novel targets for treating inflammatory bowel disease using Mendelian randomization analysis. International Journal of Colorectal Disease. 39(1). 165–165. 4 indexed citations
3.
Xiao, Xun, Jinting Wang, Jun Ma, et al.. (2024). Interferon lambda 4 is a gut antimicrobial protein. Proceedings of the National Academy of Sciences. 121(44). e2409684121–e2409684121. 2 indexed citations
4.
Pan, Jay, Xiaolin Wei, Hao Lu, et al.. (2024). List prices and clinical value of anticancer drugs in China, Japan, and South Korea: a retrospective comparative study. The Lancet Regional Health - Western Pacific. 47. 101088–101088. 6 indexed citations
5.
Lu, Hao, Wenjia Lu, Xiaodan Li, et al.. (2024). Antibacterial efficacy and mechanism of Cyprinus carpio chemokine-derived L-10 against multidrug-resistant Escherichia coli infections. International Journal of Antimicrobial Agents. 63(4). 107104–107104. 3 indexed citations
6.
Lu, Hao, et al.. (2023). No causal association between COVID-19 and sepsis: a bidirectional two-sample Mendelian randomization study. Frontiers in Immunology. 14. 1183489–1183489. 5 indexed citations
7.
8.
Lu, Hao, et al.. (2023). Gut microbiota and Sjögren’s syndrome: a two-sample Mendelian randomization study. Frontiers in Immunology. 14. 1187906–1187906. 22 indexed citations
9.
Dong, Wenqi, Gaoyan Wang, Jiajia Feng, et al.. (2022). MiR-25 blunts autophagy and promotes the survival of Mycobacterium tuberculosis by regulating NPC1. iScience. 25(5). 104279–104279. 15 indexed citations
10.
Lu, Wenjia, Hao Lu, Gaoyan Wang, et al.. (2021). Function of Rhs proteins in porcine extraintestinal pathogenic Escherichia coli PCN033. The Journal of Microbiology. 59(9). 854–860. 6 indexed citations
11.
Hu, Linlin, Chenchen Wang, Wenjia Lu, et al.. (2020). BaeSR activates type VI secretion system expression in porcine extra-intestinal pathogenic Escherichia coli to enhance bacterial resistance to zinc stress. Microbial Pathogenesis. 147. 104357–104357. 5 indexed citations
12.
Dong, Wenqi, Rui Wang, Pei Li, et al.. (2020). Orphan response regulator Rv3143 increases antibiotic sensitivity by regulating cell wall permeability in Mycobacterium smegmatis. Archives of Biochemistry and Biophysics. 692. 108522–108522. 9 indexed citations
13.
Lu, Hao, Manli Liu, Wenjia Lu, et al.. (2020). Repurposing Ellipticine Hydrochloride to Combat Colistin-Resistant Extraintestinal Pathogenic E. coli (ExPEC). Frontiers in Microbiology. 11. 806–806. 8 indexed citations
14.
Hart, Amy C., Lynn M. Abell, Junqing Guo, et al.. (2019). Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage. ACS Medicinal Chemistry Letters. 11(3). 266–271. 31 indexed citations
15.
Lin, Zeyu, Joseph L. Cantone, Hao Lu, et al.. (2016). Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors. PLoS Pathogens. 12(11). e1005990–e1005990. 16 indexed citations
16.
Rigat, Karen, Hao Lu, Ying-Kai Wang, et al.. (2014). Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase. Journal of Biological Chemistry. 289(48). 33456–33468. 17 indexed citations
17.
Lu, Hao, Mónica Fernández-Franzón, Guillermina Font, & María-José Ruiz. (2012). Toxicity evaluation of individual and mixed enniatins using an in vitro method with CHO-K1 cells. Toxicology in Vitro. 27(2). 672–680. 44 indexed citations
18.
Schiebel, J., et al.. (2012). Staphylococcus aureus FabI: Inhibition, Substrate Recognition, and Potential Implications for In Vivo Essentiality. Structure. 20(5). 802–813. 74 indexed citations
19.
Kuper, Jochen, Hao Lu, Steffen Wagner, et al.. (2012). Structure of the Yersinia pestis FabV Enoyl-ACP Reductase and Its Interaction with Two 2-Pyridone Inhibitors. Structure. 20(1). 89–100. 20 indexed citations
20.
Gromeier, Matthias, Hao Lu, Günter Bernhardt, et al.. (1995). The Human Poliovirus Receptor. Annals of the New York Academy of Sciences. 753(1). 19–36. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sergio Lociuro Breakdown of academic impact, for papers by Anatoly Severin Breakdown of academic impact, for papers by Tania J. Lupoli Breakdown of academic impact, for papers by David J. Haydon Breakdown of academic impact, for papers by Rajmohan Rajamuthiah Breakdown of academic impact, for papers by Anjan Debnath Breakdown of academic impact, for papers by Namita Surolia Breakdown of academic impact, for papers by Gianfranco De Pascale Breakdown of academic impact, for papers by Mack Kuo Breakdown of academic impact, for papers by Ellen Z. Baum
Rankless by CCL
2026